"10.1371_journal.pone.0021338","plos one","2011-06-21T00:00:00Z","Michael Osthoff; Mira Katan; Felix Fluri; Philipp Schuetz; Roland Bingisser; Ludwig Kappos; Andreas J Steck; Stefan T Engelter; Beat Mueller; Mirjam Christ-Crain; Marten Trendelenburg","Laboratory of Clinical Immunology, Department of Biomedicine and Clinic for Internal Medicine, University Hospital Basel, Basel, Switzerland; Department of Endocrinology, University Hospital Basel, Basel, Switzerland; Department of Neurology, University Hospital Basel, Basel, Switzerland; Department of Emergency Medicine, University Hospital Basel, Basel, Switzerland; Medical University Clinic, Kantonsspital Aarau, Aarau, Switzerland; Harvard School of Public Health, Boston, Massachusetts, United States of America","Conceived and designed the experiments: MO MK MT. Performed the experiments: MO. Analyzed the data: MO MK PS. Contributed reagents/materials/analysis tools: FF RB LK AJS STE BM MC-C. Wrote the paper: MO MK. Critically revised the article for important intellectual content: FF RB LK AJS STE BM MCC MT.","Drs. Osthoff, Fluri, Bingisser, Steck, Engelter, and Mueller report no disclosures. Dr. Schuetz received support from Brahms and BioMerieux for speaking engagements. Dr. Kappos has received payments from several companies regarding his research within the field of multiple sclerosis research unrelated to this trial. Dr. Christ-Crain received speaking honoraria from Brahms. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2011","06","Michael Osthoff","MO",11,TRUE,3,1,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
